Form 4: Dolby CEO Yeaman Exercises Options, Sells Shares & Gifts Stock

Dolby Laboratories CEO Kevin Yeaman exercised stock options, sold a portion of the acquired shares under a 10b5-1 plan, and gifted shares for charitable purposes.

Summary

• Kevin J. Yeaman, President and CEO of Dolby Laboratories, Inc. (DLB), reported multiple transactions involving Class A Common Stock.
• On November 24, 2025, Mr. Yeaman exercised two sets of employee stock options: 25,000 shares at an exercise price of $45.50 per share and 11,699 shares at an exercise price of $64.60 per share.
• Immediately following the option exercises on November 24, 2025, Mr. Yeaman sold 36,699 shares of Class A Common Stock at a weighted average price of $66.9066 per share. This sale was executed under a Rule 10b5-1 trading plan adopted on February 28, 2025, with individual transaction prices ranging from $66.53 to $67.37.
• On November 26, 2025, Mr. Yeaman gifted 16,348 shares of Class A Common Stock to a Donor-Advised Fund for charitable purposes.
• Following these reported transactions, Mr. Yeaman beneficially owns 98,377 shares indirectly through the Kevin and Rachel Yeaman Family Trust, 127,735 shares directly underlying restricted stock units (subject to forfeiture until vesting), and 2.5592 shares indirectly through a son.
• The exercised options included a fully vested option for a total of 194,399 shares (25,000 exercised) and a performance-based option where 61,500 shares vested (75% of the target 82,000 shares), with 11,699 exercised.

Sentiment

Score: 5

Explanation: The filing details routine insider transactions including option exercises, a planned stock sale, and a charitable gift, which are common activities for executives and do not inherently indicate a strong positive or negative sentiment about the company's immediate prospects.

Positives

• The exercise of stock options indicates management's engagement with their compensation structure and belief in the company's value at the time of grant.
• A charitable donation of 16,348 shares to a Donor-Advised Fund demonstrates corporate social responsibility and philanthropic activity.

Negatives

• The sale of 36,699 shares by an insider, even under a pre-planned 10b5-1 arrangement, reduces their direct beneficial ownership in the company.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing details routine insider transactions by a senior executive, which are common across all industries as part of executive compensation and personal financial planning. It does not provide specific insights into broader industry trends or competitive positioning.

Corporate Governance

Related Party Transactions

• Indirect beneficial ownership of 98,377 shares of Class A Common Stock is held through the Kevin and Rachel Yeaman Family Trust dated May 14, 2009.
• Indirect beneficial ownership of 2.5592 shares of Class A Common Stock is held by a son.

Stakeholder Impact

• Shareholders are informed of insider trading activity, which can influence perceptions of management's confidence in the company, though these transactions appear routine.
• The charitable gift of shares contributes to the company's broader social responsibility profile, potentially enhancing its reputation among community stakeholders.

Next Steps

• The remaining unexercised portions of the employee stock options will continue to be subject to their respective vesting schedules and expiration dates.

Key Dates

Recommendation

The Form 4 details routine insider transactions by the CEO, including the exercise of stock options, a pre-planned sale of shares under a 10b5-1 plan, and a charitable gift. These actions are common for executives managing their compensation and personal finances and do not provide new fundamental information to alter an investment thesis. Therefore, a 'hold' recommendation is appropriate as the filing does not present new catalysts for a 'buy' or 'sell' decision.

Keywords

Dolby Laboratories, DLB, SEC Form 4, Insider Trading, Stock Options, Share Sale, Charitable Gift, Kevin Yeaman, CEO, 10b5-1 Plan